+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Arsenic trioxide exerts anti-lung cancer activity by inhibiting angiogenesis

Arsenic trioxide exerts anti-lung cancer activity by inhibiting angiogenesis

Current Cancer Drug Targets 14(6): 557-566

Arsenic trioxide (As2O3) has been used in the clinic for the treatment of acute promyelocytic 1eukemia and some solid tumors. However, its effectiveness against lung cancer has not been well demonstrated, and the underlying mechanism(s) of action remain unclear. In the present study, we found that As2O3 significantly inhibited the growth of non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) xenograft tumors. It was observed to have antiangiogenic effects in xenograft models and matrigel pellets. It also significantly inhibited the expression of VEGF-A, VEGFR-2, HIF-1α, Dll4 and Notch-1 in vivo. Moreover, As2O3 also inhibited the expression of HIF-1α, VEGFR-2, Dll4, and Notch-1 in lung cancer cell lines and human umbilical vein endothelial cells. These findings suggest that As2O3 has significant anti-lung cancer activity, which may occur as a result of the antiangiogenic effects caused by the downregulation of the VEGF and Dll4-Notch signaling pathways.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 051637111

Download citation: RISBibTeXText

PMID: 25088040

Related references

Arsenic trioxide exerts its anti-leukemic effect by inhibiting angiogenesis. Blood 92(10 Suppl. 1 Part 1-2): 598A, 1998

Arsenic trioxide exerts antimyeloma effects by inhibiting activity in the cytoplasmic substrates of histone deacetylase 6. Plos one 7(2): E32215, 2012

Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction. Journal of Experimental and Clinical Cancer Research 28: 110, 2009

Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation. Tumour Biology 36(4): 2323-2334, 2015

Mechanism of arsenic trioxide inhibiting angiogenesis in multiple myeloma. Journal of Huazhong University of Science and Technology. Medical Sciences 26(1): 43-46, 2006

Arsenic trioxide exerts antitumor activity through regulatory T cell depletion mediated by oxidative stress in a murine model of colon cancer. Journal of Immunology 189(11): 5171-5177, 2012

Interaction of EZH2 and P65 is involved in the arsenic trioxide-induced anti-angiogenesis in human triple-negative breast cancer cells. Cell Biology and Toxicology 35(4): 361-371, 2019

Inhibition of transforming growth factor beta/SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancer. Cancer Science 105(12): 1541-1549, 2014

Anti-leukemic and anti-angiogenesis efficacy of arsenic trioxide in new cases of acute promyelocytic leukemia. Leukemia and Lymphoma 47(1): 81-88, 2006

Salinomycin exerts anti-angiogenic and anti-tumorigenic activities by inhibiting vascular endothelial growth factor receptor 2-mediated angiogenesis. Oncotarget 7(18): 26580-26592, 2016

Anti-angiogenic effect of arsenic trioxide in lung cancer via inhibition of endothelial cell migration, proliferation and tube formation. Oncology Letters 14(3): 3103-3109, 2017

Bortezomib combined with histone deacetylase inhibitor ITF2357 or arsenic trioxide exerts aynergistic anti-proliferative and pro-apoptotic effect on P39 cells. Journal of Clinical Oncology 26(15_Suppl): 18022-18022, 2016

Triptolide exerts an anti-tumor effect on non‑small cell lung cancer cells by inhibiting activation of the IL‑6/STAT3 axis. International Journal of Molecular Medicine 44(1): 291-300, 2019

Cardamonin exerts anti-gastric cancer activity via inhibiting LncRNA-PVT1-STAT3 axis. Bioscience Reports 39(5):, 2019

Arsenic trioxide transarterial chemoembolization with and without additional intravenous administration of arsenic trioxide in unresectable hepatocellular carcinoma with lung metastasis: a single-blind, randomized trial. Journal of Cancer Research and Clinical Oncology 141(6): 1103-1108, 2015